The new GSK scholarship will help exceptional students access a world-class education and graduate with the skills to make a positive impact in society.
We are delighted to be able to provide a full Scholarship for an exceptional UK student from a non-traditional and low-income background to study for a one-year Masters degree at Cambridge University through membership of Lucy Cavendish for 2024 entry.
This Scholarship is for students studying Masters subjects related to Engineering, with a preference for Chemical Engineering.
Diversity, Equity and Inclusion Lead, R&D at GSK, Dr Lamont Terrell says, “GSK is proud to partner with Lucy Cavendish College and sponsor this graduate scholarship aimed at fostering diversity, equity, and inclusion in STEM. We are committed to an inclusive and diverse workforce. And by investing in this fellowship, we aim to bridge the diversity gap in the scientific community and build a pipeline of talented diverse scientists by increasing access to pursue and excel in STEM education.”
We are incredibly grateful to GSK for their generous gift, which will help future leaders
take up their offers to study at Lucy Cavendish, benefitting from being part of a world-class research community and supportive environment, thrive at Cambridge, and progress into their chosen careers, going on to leadership positions where they can help to solve some of the world’s pressing issues.
Lucy Cavendish College President, Professor Dame Madeleine Atkins, said, “We are incredibly grateful for the significant generosity of GSK. Their gift will help us in our mission to provide more students from disadvantaged backgrounds with a life-changing Cambridge education, enabling them to reach their full academic potential and go on to solve some of the major issues facing humankind and our planet.”
About GSK
GSK is a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. They aim to positively impact the health of 2.5 billion people by the end of 2030. GSK prioritises innovation in vaccines and specialty medicines, maximising the increasing opportunities to prevent and treat disease. At the heart of this is their R&D focus on the science of the immune system, human genetics, genomics and advanced technologies, and their world-leading capabilities in vaccines and medicines development. GSK focuses on four therapeutic areas: infectious diseases, HIV, respiratory/immunology, and oncology.